| |
| |
|
| Insider
Information: |
Abercrombie George B |
| Relationship: |
|
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
347,320 |
|
|
Indirect Shares
|
131,194 |
|
|
| Direct
Value |
$4,532,199 |
|
|
|
Indirect Value
|
$88,687 |
|
|
| Total
Shares |
478,514 |
|
|
| Total
Value |
$4,620,886 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -13.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alaunos Therapeutics |
TCRT |
Director |
2010-04-05 |
25,000 |
2010-04-05 |
0 |
Premium* |
|
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2023-06-13 |
29,611 |
2013-03-05 |
0 |
Premium* |
|
|
Innoviva Inc |
INVA |
Sr. VP & Chief Comm. O... |
2018-08-21 |
285,479 |
2014-06-19 |
0 |
Premium* |
|
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
|
2019-08-31 |
7,230 |
2019-08-31 |
131,194 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INVA |
Innoviva Inc |
Sr. VP & Chief Comm. Officer |
• – – |
2017-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
106,718 |
275,193 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr. VP & Chief Comm. Officer |
• – – |
2016-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
92,587 |
175,554 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr. VP & Chief Comm. Officer |
• – – |
2018-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
74,444 |
309,917 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2021-09-10 |
4 |
S |
$15.09 |
$1,116,660 |
D/D |
(74,000) |
0 |
0 |
% |
|
| INVA |
Innoviva Inc |
Sr. VP, Corp. Partnerships |
• – – |
2015-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
71,429 |
81,429 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2021-09-10 |
4 |
OE |
$1.71 |
$202,710 |
D/D |
71,000 |
74,000 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Director |
– • – |
2010-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
16,745 |
29,611 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr. VP & Chief Comm. Officer |
• – – |
2018-02-20 |
4 |
D |
$16.44 |
$254,820 |
D/D |
(15,500) |
243,473 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr. VP, Corp. Partnerships |
• – – |
2014-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr. VP & Chief Comm. Officer |
• – – |
2018-02-21 |
4 |
AS |
$16.51 |
$132,100 |
D/D |
(8,000) |
235,473 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr. VP & Chief Comm. Officer |
• – – |
2018-05-21 |
4 |
S |
$14.40 |
$115,202 |
D/D |
(8,000) |
299,159 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr. VP & Chief Comm. Officer |
• – – |
2018-08-21 |
4 |
AS |
$14.11 |
$112,840 |
D/D |
(8,000) |
285,479 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2021-05-10 |
4 |
S |
$12.70 |
$88,900 |
D/D |
(7,000) |
3,000 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2021-05-24 |
4 |
OE |
$2.63 |
$17,534 |
D/D |
6,667 |
9,667 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2021-05-24 |
4 |
AS |
$13.90 |
$92,671 |
D/D |
(6,667) |
3,000 |
0 |
% |
|
| INVA |
Innoviva Inc |
Sr. VP & Chief Comm. Officer |
• – – |
2018-08-20 |
4 |
D |
$14.08 |
$79,974 |
D/D |
(5,680) |
293,479 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr. VP & Chief Comm. Officer |
• – – |
2016-02-19 |
4 |
D |
$12.28 |
$66,017 |
D/D |
(5,376) |
170,178 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr. VP & Chief Comm. Officer |
• – – |
2017-02-20 |
4 |
D |
$12.04 |
$64,474 |
D/D |
(5,355) |
269,838 |
0 |
- |
|
| INVA |
Innoviva Inc |
Sr. VP & Chief Comm. Officer |
• – – |
2017-11-21 |
4 |
AS |
$13.26 |
$69,145 |
D/D |
(5,215) |
258,651 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2021-07-15 |
4 |
OE |
$2.63 |
$13,150 |
D/D |
5,000 |
8,000 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2021-07-15 |
4 |
AS |
$15.69 |
$78,450 |
D/D |
(5,000) |
3,000 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2021-09-15 |
4 |
OE |
$2.63 |
$13,150 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2021-09-15 |
4 |
AS |
$15.06 |
$75,300 |
D/D |
(5,000) |
0 |
0 |
% |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2021-11-15 |
4 |
AS |
$12.27 |
$61,350 |
D/D |
(5,000) |
0 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
